Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
54 | 89702 | 41.5 | 74% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
475 | 15008 | ALLOPREGNANOLONE//PREMATURE EJACULATION//NEUROSTEROID |
612 | 13263 | POLYCYSTIC OVARY SYNDROME//PCOS//HYPERANDROGENISM |
645 | 12871 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL |
754 | 11793 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |
1778 | 5832 | ISOFLAVONES//GENISTEIN//DAIDZEIN |
1801 | 5753 | ALDOSE REDUCTASE//ALDO KETO REDUCTASE//17 BETA HYDROXYSTEROID DEHYDROGENASE |
2508 | 3401 | 2 METHOXYESTRADIOL//INDOLE 3 CARBINOL//3 3 DIINDOLYLMETHANE |
3227 | 1500 | OLEOYL ESTRONE//APOLIPOPROTEIN D//BREAST CYST FLUID |
3840 | 595 | 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MENOPAUSE | Author keyword | 2135 | 48% | 4% | 3252 |
2 | POLYCYSTIC OVARY SYNDROME | Author keyword | 1389 | 59% | 2% | 1560 |
3 | ESTROGEN | Author keyword | 1256 | 33% | 4% | 3163 |
4 | TAMOXIFEN | Author keyword | 1252 | 47% | 2% | 1951 |
5 | HORMONE REPLACEMENT THERAPY | Author keyword | 1235 | 57% | 2% | 1477 |
6 | ISOFLAVONES | Author keyword | 1038 | 64% | 1% | 1022 |
7 | MATURITAS | Journal | 1001 | 47% | 2% | 1560 |
8 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | Journal | 918 | 56% | 1% | 1120 |
9 | AROMATASE INHIBITORS | Author keyword | 795 | 58% | 1% | 918 |
10 | ALLOPREGNANOLONE | Author keyword | 791 | 80% | 1% | 493 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MENOPAUSE | 2135 | 48% | 4% | 3252 | Search MENOPAUSE | Search MENOPAUSE |
2 | POLYCYSTIC OVARY SYNDROME | 1389 | 59% | 2% | 1560 | Search POLYCYSTIC+OVARY+SYNDROME | Search POLYCYSTIC+OVARY+SYNDROME |
3 | ESTROGEN | 1256 | 33% | 4% | 3163 | Search ESTROGEN | Search ESTROGEN |
4 | TAMOXIFEN | 1252 | 47% | 2% | 1951 | Search TAMOXIFEN | Search TAMOXIFEN |
5 | HORMONE REPLACEMENT THERAPY | 1235 | 57% | 2% | 1477 | Search HORMONE+REPLACEMENT+THERAPY | Search HORMONE+REPLACEMENT+THERAPY |
6 | ISOFLAVONES | 1038 | 64% | 1% | 1022 | Search ISOFLAVONES | Search ISOFLAVONES |
7 | AROMATASE INHIBITORS | 795 | 58% | 1% | 918 | Search AROMATASE+INHIBITORS | Search AROMATASE+INHIBITORS |
8 | ALLOPREGNANOLONE | 791 | 80% | 1% | 493 | Search ALLOPREGNANOLONE | Search ALLOPREGNANOLONE |
9 | ESTROGEN RECEPTOR | 770 | 35% | 2% | 1790 | Search ESTROGEN+RECEPTOR | Search ESTROGEN+RECEPTOR |
10 | HOT FLASHES | 676 | 86% | 0% | 344 | Search HOT+FLASHES | Search HOT+FLASHES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POSTMENOPAUSAL WOMEN | 3708 | 31% | 11% | 9811 |
2 | HORMONE REPLACEMENT THERAPY | 1610 | 41% | 3% | 3064 |
3 | PHYTO ESTROGENS | 1317 | 57% | 2% | 1571 |
4 | ESTRADIOL | 1172 | 31% | 4% | 3141 |
5 | ESTROGEN PLUS PROGESTIN | 1124 | 55% | 2% | 1423 |
6 | ESTROGEN | 1062 | 24% | 4% | 3949 |
7 | TAMOXIFEN | 940 | 33% | 3% | 2356 |
8 | CONJUGATED EQUINE ESTROGENS | 882 | 79% | 1% | 561 |
9 | REPLACEMENT THERAPY | 805 | 28% | 3% | 2442 |
10 | HORMONE BINDING GLOBULIN | 797 | 53% | 1% | 1071 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATURITAS | 1001 | 47% | 2% | 1560 |
2 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 918 | 56% | 1% | 1120 |
3 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 762 | 28% | 3% | 2369 |
4 | CLIMACTERIC | 480 | 58% | 1% | 550 |
5 | BREAST CANCER RESEARCH AND TREATMENT | 249 | 18% | 1% | 1229 |
6 | STEROIDS | 206 | 21% | 1% | 865 |
7 | GYNECOLOGICAL ENDOCRINOLOGY | 168 | 24% | 1% | 621 |
8 | CANCER CAUSES & CONTROL | 163 | 22% | 1% | 666 |
9 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 159 | 16% | 1% | 933 |
10 | HORMONES AND BEHAVIOR | 147 | 21% | 1% | 634 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The protective effects of estrogen on the cardiovascular system | 1999 | 1668 | 124 | 87% |
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer | 2015 | 5 | 150 | 89% |
Mechanisms of disease: Estrogen carcinogenesis in breast cancer | 2006 | 709 | 99 | 79% |
Medical progress: Polycystic ovary syndrome | 2005 | 718 | 124 | 89% |
Metformin in Cancer Treatment and Prevention | 2015 | 5 | 63 | 70% |
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis | 2011 | 198 | 205 | 81% |
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials | 2013 | 90 | 83 | 75% |
Update on breast cancer risk prediction and prevention | 2015 | 5 | 53 | 68% |
Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection | 2015 | 4 | 188 | 81% |
Estrogen receptors: How do they signal and what are their targets | 2007 | 547 | 303 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STERIX LTD | 97 | 80% | 0.1% | 60 |
2 | COMPARAT MED CLIN | 94 | 80% | 0.1% | 59 |
3 | PSYCHIAT NEUROSEXOL | 72 | 81% | 0.0% | 43 |
4 | GRP BEHAV NEUROENDOCRINOL | 70 | 57% | 0.1% | 84 |
5 | REPROD MED CHILD DEV | 67 | 47% | 0.1% | 105 |
6 | STEROID HORMONES SECT | 65 | 76% | 0.1% | 45 |
7 | ROBERT HAGUE DIABET ENDOCRINOL | 56 | 100% | 0.0% | 19 |
8 | ONCOL MOL ENDOCRINOL | 51 | 36% | 0.1% | 112 |
9 | UMEA NEUROSTEROID | 50 | 73% | 0.0% | 38 |
10 | ENDOCRINOL METAB MED STERIX LTD | 45 | 94% | 0.0% | 16 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003413 | STEROIDS//OSW 1//SQUALAMINE |
2 | 0.0000002695 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//HUMAN REPRODUCTION |
3 | 0.0000002448 | BREAST CANCER//BREAST//BRCA1 |
4 | 0.0000002268 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//ENDOMETRIUM |
5 | 0.0000002156 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
6 | 0.0000002053 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//ALDOSTERONE |
7 | 0.0000002042 | PROSTATE CANCER//PROSTATIC NEOPLASMS//RADICAL PROSTATECTOMY |
8 | 0.0000001878 | KAWASAKI DISEASE//MUCOCUTANEOUS LYMPH NODE SYNDROME//SUPERANTIGEN |
9 | 0.0000001668 | ERECTILE DYSFUNCTION//PENIS//HYPOSPADIAS |
10 | 0.0000001536 | GHRELIN//LEPTIN//ADIPONECTIN |